Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Parkinsonism-hyperpyrexia syndrome due to abrupt withdrawal of amantadine

Cheung YF, Hui CH, Chan JH.

Hong Kong Med J. 2011 Apr;17(2):167-8.

Camptocormia: as the first sign of Parkinson's disease

Oh YS, Kim JS, Chung SW, Kim YD, Lee KS.

Can J Neurol Sci. 2011 Mar;38(2):370-2. doi: 10.1017/s0317167100011665.

Cdk5: multitasking between physiological and pathological conditions

Lopes JP, Agostinho P.

Prog Neurobiol. 2011 Jun;94(1):49-63. doi: 10.1016/j.pneurobio.2011.03.006. Epub 2011 Apr 5.

Therapeutic applications of antibodies in non-infectious neurodegenerative diseases

Krishnamurthy PK, Sigurdsson EM.

N Biotechnol. 2011 Sep;28(5):511-7. doi: 10.1016/j.nbt.2011.03.020. Epub 2011 Apr 5.

Bone mineral density in adults disabled through acquired neurological conditions: a review

Smith É, Carroll Á.

J Clin Densitom. 2011 Apr-Jun;14(2):85-94. doi: 10.1016/j.jocd.2010.12.002. Epub 2011 Apr 6.

Validity of the Mattis Dementia Rating Scale to detect mild cognitive impairment in Parkinson's disease and REM sleep behavior disorder

Villeneuve S, Rodrigues-Brazète J, Joncas S, Postuma RB, Latreille V, Gagnon JF.

Dement Geriatr Cogn Disord. 2011;31(3):210-7. doi: 10.1159/000326212. Epub 2011 Apr 7.

Amino acid management of Parkinson's disease: a case study

Hinz M, Stein A, Uncini T.

Int J Gen Med. 2011 Feb 28;4:165-74. doi: 10.2147/IJGM.S16621.

Infected internal pulse generator: Treatment without removal

Themistocleous MS, Boviatsis EJ, Stathis P, Stavrinou LC, Sakas DE.

Surg Neurol Int. 2011 Mar 23;2:33. doi: 10.4103/2152-7806.78240.

Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action

Lalive PH, Neuhaus O, Benkhoucha M, Burger D, Hohlfeld R, Zamvil SS, Weber MS.

CNS Drugs. 2011 May;25(5):401-14. doi: 10.2165/11588120-000000000-00000.

Delayed clinical improvement after deep brain stimulation-related subdural hematoma. Report of 4 cases

Oyama G, Okun MS, Zesiewicz TA, Tamse T, Romrell J, Zeilman P, Foote KD.

J Neurosurg. 2011 Aug;115(2):289-94. doi: 10.3171/2011.3.JNS101424. Epub 2011 Apr 8.

Aggravated stuttering following subthalamic deep brain stimulation in Parkinson's disease--two cases

Toft M, Dietrichs E.

BMC Neurol. 2011 Apr 8;11:44. doi: 10.1186/1471-2377-11-44.

Aromatase and its inhibition in behaviour, obsessive compulsive disorder and parkinsonism

Boon WC, Horne MK.

Steroids. 2011 Jul;76(8):816-9. doi: 10.1016/j.steroids.2011.02.031. Epub 2011 Apr 6.

Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications

Pavan B, Paganetto G, Dalpiaz A.

Drug Discov Today. 2011 Jun;16(11-12):520-9. doi: 10.1016/j.drudis.2011.03.010. Epub 2011 Apr 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias